<DOC>
	<DOCNO>NCT00722540</DOCNO>
	<brief_summary>This trial conduct Europe . The aim clinical trial investigate safety , tolerability , pharmacokinetics pharmacodynamics NNC126-0083 healthy male Japanese subject .</brief_summary>
	<brief_title>Dose Study Healthy Japanese Males Investigating Safety , Pharmacokinetics Pharmacodynamics NNC126-0083</brief_title>
	<detailed_description />
	<criteria>Healthy male subject Japanese passport Japanese born parent Body Mass Index ( BMI , kg/m2 ) 18.0 27.0 , inclusive Subjects must good health accord age A history presence cancer , diabetes , clinically significant cardiovascular , respiratory , metabolic , renal , hepatic , gastrointestinal , endocrinological , haematological , dermatological , venereal , neurological , psychiatric disease major disease History illnesses disease , opinion Investigator might confound result trial pose additional risk administer trial product subject Any clinically significant abnormal haematology , biochemistry urinalysis screening test , judge Investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>